Your browser doesn't support javascript.
loading
Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08-20.
Patt, Yehuda; Rojas-Hernandez, Cristhiam; Fekrazad, Houman Mohammad; Bansal, Pranshu; Lee, Fa Chyi.
Afiliação
  • Patt Y; Department of Hematology/oncology, University of New Mexico, Albuquerque, New Mexico, USA.
  • Rojas-Hernandez C; Department of Hematology/oncology, MD Anderson Cancer Center, Houston, Texas.
  • Fekrazad HM; Department of Hematology/oncology, City of Hope Cancer Center, Duarte, California, USA.
  • Bansal P; Department of Hematology/oncology, University of New Mexico, Albuquerque, New Mexico, USA Pranshu.doc@gmail.com.
  • Lee FC; Department of Hematology/oncology, University of New Mexico, Albuquerque, New Mexico, USA.
Oncologist ; 22(10): 1158-e116, 2017 10.
Article em En | MEDLINE | ID: mdl-28687627

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Niacinamida / Carcinoma Hepatocelular / Capecitabina / Neoplasias Hepáticas / Antineoplásicos Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Niacinamida / Carcinoma Hepatocelular / Capecitabina / Neoplasias Hepáticas / Antineoplásicos Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article